Upcoming Medical Conferences in Spain

Progress and Controversies in Gynecologic Oncology is organized by prIME Oncology and will be held from Jan 25 - 26, 2019 at Crowne Plaza Barcelona - Fira Center, Barcelona, Cataluna, Spain. The target audience for this medical event is gynecologists, oncologists, radiation therapists, surgeons, pathologists, and other practitioners, including allied health professionals, involved in the diagnosis and management of gynecologic malignancies. Conference Description : Progress and Controversies in Gynecologic Oncology: 2019 prIME Oncology Conference to get the latest information on gynecologic malignancies from the world’s leading experts. The latest clinical trial data and practical information will be presented in an interactive format, fostering discussions that will impact clinical outcomes for your patients. Conference Objectives are : • Develop practical approaches for the management of cervical cancer and endometrial cancer. • Assess standard and emerging therapeutic options for ovarian cancer and describe how the options impact patient outcomes. • Describe the potential role of immunotherapy in the management of gynecologic malignancies. • Discuss contemporary strategies for the management of various rare gynecologic malignancies. Additional details will be posted as soon as they are available.

Lower and Upper Extremity Workshop is organized by UltraDissection Spain EchoTraining School and will be held from Jan 26 - 27, 2019 at UAM Medical Campus, Madrid, Spain. The target audience for this medical event is professionals interested in studying and improving anatomy, and its impact on ultrasound in real situations Conference Objectives: Exclusive Methodology: It is the bodies themselves that solve our doubts. • 5 people per station. • 2 Thiel cadavers to learn. • Thiel cadavers: ○ You will observe through ultrasound ○ Needling practice • Test yourself In the cadaver after dissection: Thiel cadavers Additional details will be posted as soon as they are available.

Tracking Cancer: Detection and Monitoring, from Diagnosis to Therapy is organized by European Association for Cancer Research (EACR) and will be held from Feb 04 - 06, 2019 at CosmoCaixa Barcelona, Barcelona, Catalonia, Spain. Who will attend? The conference will bring together those working across technology and data analysis, drug development, and clinical management of cancer. Participation is welcome from PhD students through to group leaders, from both academia and industry, and from the lab to the clinic. Conference Description : The first EACR conference on Tracking Cancer will highlight the newest approaches to cancer detection and monitoring, from diagnosis through therapy and progression. It will be an interactive environment to discuss current challenges and ways to move the field forward. The meeting will foster the exchange of ideas and spur multidisciplinary collaborations. The programme includes multiple opportunities for networking and interaction. As well as the lively Poster Discussion sessions, there will be Panel Discussions at the end of each day for speakers and participants to engage beyond discussing the data, into envisioning a future that integrates rapidly evolving technologies into basic, translational and clinical cancer research. Conference Topics : • Circulating Tumour Cells. • Imaging. • Liquid biopsies. • Clinical trial design. • Immunotherapy. • Genome analysis. Additional details will be posted as soon as they are available.

7th Multidisciplinary Bone and Soft Tissue Tumors Madrid Course is organized by Provalentia Congresses / Provalentia Congresos and will be held from Feb 06 - 09, 2019 at Madrid, Spain. Formative Credits: The BSTT Course has been accredited by European Accreditation Council for Continuing Medical Education (EACCME) with 25 European CME credits. In this course of 2019, we have the invaluable collaboration of Andrés Redondo, sarcoma medical oncologist, putting emphasis on the medical treatment of soft tissue sarcomas. The course offers to all multidisciplinary sarcoma team greater knowledge of the scientific basis of musculoskeletal pathology, in which the roles of the orthopedic surgeon, pathologist and radiologist overlap. This is complemented by the range of different treatment options, both general (medical oncology) and local (orthopedic oncology surgery, radiation oncology and reconstructive and reparative surgery. Additional details will be posted as soon as they are available.

4th Annual European Congress on Hematology: Focus on Leukemia, Lymphoma, and Myeloma is organized by Physicians' Education Resource, LLC (PER) and will be held from Feb 07 - 09, 2019 at Hilton Barcelona, Barcelona, Cataluna, Spain. The Target Audience for This Medical Event is directed toward medical oncologists. Nurse practitioners, nurses, physician assistants, pharmacists, researchers and other health care professionals interested in the treatment of cancer will be invited to participate.   Description: At this congress, clinicians will be able to enhance their skills to contextualize the wealth of emerging data on how to treat hematologic malignancies, update their clinical decision-making based upon individual patient/tumor characteristics and mitigation of adverse events, and learn how to apply novel management strategies in their practices to improve patient outcomes. Our abilities to characterize tumors, stratify risk with evolving testing technologies, and manage leukemic, lymphoid and myeloid malignancies continue to change at a rapid pace. Sophisticated molecular techniques, which are used to individualize risk stratification and guide treatment, along with novel targeted and immunotherapeutic options, have expanded the treatment armamentarium in the field. Given the realities of contemporary practice, practitioners can have difficulty placing practice-changing data into its proper clinical context and applying these strategies to evolving treatment paradigms in the setting of hematologic malignancies. It also remains a challenge for oncologists and hematologists to attend national and international oncology society meetings where fast-paced practice-changing information is typically presented, resulting in an inability for them to maintain state-of-the-art care for their patients. The congress is organized in an exciting case-based format, in which leading international experts will participate in informative lectures and panels that will discuss recent data sets. What sets this meeting apart are the interactive discussions in which participants will be challenged to engage directly with renowned faculty to share their perspectives, experiences, and methods for addressing clinical challenges in the management of leukemic, lymphoid, and myeloid malignancies. Benefits of Attending • Place practice-changing data in its proper clinical context • Network with top hematologists, clinicians, and scientists • Apply novel management strategies to your practice to improve patient outcomes • Participate in an exciting case-based format about current challenges and controversies • Incorporate evolving treatment paradigms into the setting of hematologic malignancies • Update your clinical decision-making based upon individual patient/tumor characteristics Learning Objectives: After successful completion of this educational activity, you should be better prepared to: • Assess current and emerging risk-stratification methods and response criteria using genomic, molecular, and clinical biomarkers, and how they can be used to guide clinical decision-making in the management of leukemia, lymphoma, and myeloma malignancies • Differentiate the mechanism of action, safety, and efficacy of current and emerging targeted and cancer immunotherapies used or investigated in various types of leukemia, lymphoid, and myeloma malignancies • Assess landmark clinical trial results in the context of how they impact evolving clinical practice paradigms, and can be applied to personalize care and optimize outcomes • Identify interprofessional approaches to addressing treatment-related toxicities in patients who receive care for leukemic, lymphoid, and myeloid malignancies • Evaluate effective strategies to assess and address nonadherence to oral oncolytic therapies • Interpret recent clinical trial findings concerning novel compounds or strategies to manage leukemic, lymphoid, and myeloid malignancies • Explain the therapeutic implications of emerging data on evolving treatment paradigms for patients with leukemia, lymphoma, and myeloma malignancies in newly diagnosed and relapsed/refractory settings

Research: Evidence-Informed Practice is organized by International Chiropractic Pediatric Association (ICPA) and will be held from Feb 16 - 17, 2019 at Barcelona College of Chiropractic (BCC), Barcelona, Catalonia, Spain. The target audience for this medical event is chiropractors and students of 5th quarter/4th trimester or higher. This CME Conference has been approved for a maximum of 12 hours of continuing education credits. CE Credits Request Fee: $45 per class. This fee is additional to seminar cost and is non-refundable. Course Goal: Overview of current published research: understanding the various types of research and essentials of the case history. Application of current research and its relevance to case management in the family practice. Participants will be introduced to the methodology of preparing a case study for publication.​​ To provide the attendee with the most relevant research in the chiropractic care of children and impart the ability to critically appraise and integrate/reconcile the research findings with the chiropractic empirical/clinical experience for the purpose of teaching, research and practice. Additional details will be posted as soon as they are available.

12th International Symposium Advanced Ovarian Cancer Optimal Therapy. Update is organized by Spanish Ovarian Cancer Research Group / Grupo Espanol de Investigacion en Cancer de Ovario (GEICO), European Society for Medical Oncology (ESMO) and will be held on Feb 22, 2019 at Palau de la Musica in Valencia, Valencia, Spain. This CME Conference has been approved for a maximum of 6 ESMO-MORA category 1 points. Additional details will be posted as soon as they are available.

16th Annual European Neuroendocrine Tumor Society (ENETS) Conference is organized by European Neuroendocrine Tumor Society (ENETS) and will be held from Mar 06 - 08, 2019 at Barcelona International Convention Centre, Barcelona, Catalonia, Spain. Additional details will be posted as soon as they are available.

6th International Conference on Nutrition and Growth (N&G) is organized by Kenes Group and will be held from Mar 07 - 09, 2019 at Palace of Congresses of Valencia, Valencia, Spain. The 6th International Conference on Nutrition and Growth (NandG 2019) will provide a unique platform for discussing the interplay between nutrition and growth in children, from disease factors through to treatment. NandG is ideal for pediatricians, gastroenterologists, endocrinologists, neonatologists, dieticians, nutritionists, nurses and all those involved in child development who share a passion for exchanging ideas and analysis of pediatric nutrition. Abstract Submission Deadline: 9 October 2018 Early Bird Registration Deadline: 18 December 2018 Price: Early Bird Registration Full: EUR 450.0 Speakers: Moshe Phillip, Raanan Shamir,, Dominique Turck, Hans van Goudoever, Carlo Agostoni, Jesus Argente, Dennis Bier, Paula Crespo, Mary Fewtrell, Anita Hokken-Koelega, Kim Fleischer Michaelsen, Luis Moreno, Andrew Prentice, Virginia Stallings, Hania Szajewska, Jan-Maarten Wit, Michel Polak, Robert Rapaport, Cai Wei Time: 8:00 am to 6:00 pm Additional details will be posted as soon as they are available.

European Cardio-Oncology Symposium (ECOS) 2019 Spring Meeting is organized by Siyemi Learning and will be held from Mar 07 - 09, 2019 at NH Collection Barcelona Constanza Hotel, Barcelona, Cataluna, Spain. The European Cardio-Oncology Symposium (ECOS) 2019 Spring Meeting is an innovative, hands-on, live CME event designed for cardiologists, oncologists, specialist nurses, and other healthcare professionals involved in the cardiovascular care of patients with cancer. All participants are invited to attend a free pre-conference imaging workshop on 7 March 2019. Siyemi Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Siyemi Learning designates this live activity for a maximum of 16.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Additional details will be posted as soon as they are available.